Home / Imipenem and Cilastatin / United States
US ATC J01DH51 · updated 2 Nov 2026
Imipenem and Cilastatin shortage in United States
Is there an Imipenem and Cilastatin shortage in United States?
Yes. As of 2 Nov 2026, 1 Imipenem and Cilastatin product is reported short in United States, the first since 8 Jan 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Primaxin, Injection, 500mg (NDC 0006-3516-59) discontinuation | Merck Sharp & Dohme Corp. | 8 Jan 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).